Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000685999 | SCV000813502 | uncertain significance | Neuronal ceroid lipofuscinosis | 2022-06-04 | criteria provided, single submitter | clinical testing | This sequence change replaces alanine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 213 of the CLN5 protein (p.Ala213Ser). This variant is present in population databases (rs748549252, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with CLN5-related conditions. ClinVar contains an entry for this variant (Variation ID: 566238). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Revvity Omics, |
RCV001272147 | SCV003832400 | uncertain significance | Neuronal ceroid lipofuscinosis 5 | 2020-06-05 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001272147 | SCV001453818 | uncertain significance | Neuronal ceroid lipofuscinosis 5 | 2020-09-16 | no assertion criteria provided | clinical testing |